Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens is offering cash rewards for vaccinations, including a $5 reward from August to December and a $10 reward in September for anyone receiving vaccines at its nearly 9,000 locations. This initiative aims to combat rising flu cases, observed as flu activity in the Southern Hemisphere points to possible increases in the U.S. during the 2022-2023 season. Vaccination appointments are encouraged, allowing for co-administration of various vaccines. Additionally, Walgreens continues its 'Get a Shot. Give a Shot.' program to provide immunizations to children globally.
This August, Huggies and Walgreens are partnering for the sixth consecutive year to address diaper need in the U.S. For every pack of Huggies Diapers purchased, one day's worth of diapers will be donated to the National Diaper Bank Network, with a goal of donating up to 1 million diapers. Diaper need affects one in three families in the U.S., impacting children's health and wellbeing. Since 2011, this collaboration has provided over 300 million diapers to families in need. The initiative emphasizes the importance of access to clean diapers for children's health.
Walgreens is partnering with CAMP to offer limited-edition Ultimate Beach Day Bundles to families nationwide, promoting sun safety and summer fun. Starting August 5, families can reserve these free bundles featuring Walgreens brand health products. On August 11, an event in Domino Park, Brooklyn, will include activities like a treasure hunt and beach yoga. One bundle hides a grand prize for a beach vacation. Walgreens emphasizes their commitment to health and wellness through this initiative, showcasing their range of pharmacist-recommended products.
Walgreens Boots Alliance (WBA) has announced a quarterly dividend of 48 cents per share, marking a 0.5% increase from the previous rate. This dividend is set to be paid on September 9, 2022, to stockholders of record as of August 19, 2022. The annual dividend rate has risen from $1.91 to $1.92 per share. WBA has consistently paid dividends for over 89 years and has increased them for 47 consecutive years, reflecting the company's longstanding commitment to returning value to its shareholders.
Walgreens Boots Alliance (WBA) reported third-quarter fiscal 2022 results, with EPS from continuing operations down 73.8% to $0.33, compared to $1.27 last year. Adjusted EPS decreased 30.0% to $0.96. Sales fell 4.2% to $32.6 billion, reflecting a significant impact from AllianceRx Walgreens. Operating income showed a loss of $320 million, compared to a gain of $1.1 billion last year. Despite these challenges, retail comparable sales grew 2.4%, and Walgreens Health pro forma sales surged 65%. The company aims for $3.5 billion in annual cost savings by fiscal 2024.
Walgreens Boots Alliance (WBA) has decided to retain its Boots and No7 Beauty Company businesses after a strategic review initiated in January. Despite considerable interest from buyers, the ongoing instability in global financial markets hindered potential offers. WBA is focusing on the continued growth of Boots and No7, which have shown strong performance. CEO Rosalind Brewer noted the necessity of this decision amid challenging conditions, emphasizing the potential for future opportunities in the healthcare and beauty sectors.
Summary not available.
Walgreens is expanding its Health Corner services to over 2.27 million patients across California, New Jersey, and Ohio by summer's end. This initiative is part of a collaboration with Buckeye Health Plan to provide health services to Medicaid members in northeast Ohio. Walgreens Health Corners will enhance access to healthcare, offering services like health screenings, chronic condition management, and personalized care by Health Advisors. The number of locations will grow from 55 to about 100 by the end of 2022.
Walgreens will start administering Pfizer and Moderna COVID-19 vaccines to children aged 3 and older at select locations starting Saturday, June 25. This follows FDA Emergency Use Authorization and CDC guidance for vaccinating younger children. Parents are encouraged to schedule appointments via Walgreens.com or the Walgreens app. Walgreens pharmacists, experienced in pediatric immunizations, aim to provide comfort and education for families during the vaccination process. Notably, Walgreens has extensive experience in administering vaccines to millions of children and adolescents.
Walgreens and Greater Than AIDS are hosting the largest National HIV Testing Day event in over 250 cities on June 27, aiming to increase awareness and access to HIV testing. This initiative addresses a decline in testing during the COVID-19 pandemic, where about 13% of the 1.2 million people living with HIV in the U.S. are unaware of their status. The event will provide free, confidential testing at participating Walgreens locations, supported by local health departments and community organizations.